lisinopril
- Product NDC
- 0185-0630
- 11-digit product format
- 001850630
- Labeler code
- 0185
- Product ID
- 0185-0630_a9e1ba16-fb5e-4d16-829c-bada7356fc00
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- lisinopril
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Eon Labs, Inc.
- Application
- ANDA075994
- Marketing category
- ANDA
- Marketing start
- 2015-11-17
- Marketing end
- 2022-04-30
- Substance
- LISINOPRIL
- Active strength
- 30 mg/1
- Pharmacologic classes
- Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0185-0630-01 | 00185063001 | 100 TABLET in 1 BOTTLE (0185-0630-01) | 100 tablet | 2015-11-17 | 2021-09-30 | No | No | Current |
| 0185-0630-10 | 00185063010 | 1000 TABLET in 1 BOTTLE (0185-0630-10) | 1000 tablet | 2015-11-17 | 2022-04-30 | No | No | Current |